Audentes Therapeutics, Inc. Assets, Fair Value Disclosure
Audentes Therapeutics, Inc. had Assets, Fair Value Disclosure of $351.25 million as of 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2019-08-07
- 2019-06-30: Assets, Fair Value Disclosure $351.25M.
- 2019-03-31: Assets, Fair Value Disclosure $365.04M.
- 2018-12-31: Assets, Fair Value Disclosure $406.50M.
- 2018-09-30: Assets, Fair Value Disclosure $274.60M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2019-06-30 | $351.25M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $365.04M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $406.50M 10-Q · filed 2019-08-07 |
| 2018-09-30 | $274.60M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $150.58M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $115.83M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $118.58M 10-K · filed 2019-03-01 |
| 2017-09-30 | $143.17M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $139.30M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $77.22M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $100.46M 10-K · filed 2018-03-09 |
| 2016-09-30 | $50.50M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $52.91M 10-Q · filed 2016-09-01 |
| 2015-12-31 | $44.34M 10-K · filed 2017-03-13 |